Specifically, after binding to a target, antibodies can recruit effector cells (e
Specifically, after binding to a target, antibodies can recruit effector cells (e.g. for the study of pathogen countermeasures, have prompted companies to reconsider mAbs as antiviral providers. Public sector study into the use of mAbs against growing pathogens, such as severe acute respiratory syndrome coronavirus, may have already offered candidates for further development. Keywords:Respiratory Syncytial … [Read more…]